Reactome: A Curated Pathway Database
THIS SITE IS USED FOR CURATION AND TESTING
IT IS NOT STABLE, IS LINKED TO AN INCOMPLETE DATA SET, AND IS NOT MONITORED FOR PERFORMANCE. WE STRONGLY RECOMMEND THE USE OF OUR PUBLIC SITE

Query author contributions in Reactome

Reactome depends on collaboration between our curation team and outside experts to assemble and peer-review its pathway modules. The integration of ORCID within Reactome enables us to meet a key challenge with authoring, curating and reviewing biological information by incentivizing and crediting the external experts that contribute their expertise and time to the Reactome curation process. More information is available at ORCID and Reactome.

If you have an ORCID ID that is not listed on this page, please forward this information to us and we will update your Reactome pathway records.

Name Email address

Details on Person inflammatory bowel disease

Class:IdDisease:5683147
_displayNameinflammatory bowel disease
_timestamp2015-03-12 11:12:22
created[InstanceEdit:5683200] Jassal, Bijay, 2015-03-12
definitionAn intestinal disease characterized by inflammation located_in all parts of digestive tract.
identifier0050589
nameinflammatory bowel disease
referenceDatabase[ReferenceDatabase:1247631] DOID
(disease)[Pathway:5683159] Variant ABCB1 increases susceptibility to inflammatory bowel disease 13 [Homo sapiens]
[FailedReaction:5683197] Variant ABCB1 does not transport xenobiotics from cytosol to extracellular region [Homo sapiens]
[Reaction:9795092] JOSD2 deubiquitinates NLRP3 R779C [Homo sapiens]
[Reaction:9795107] BRISC complex deubiquitinates NLRP3 R779C [Homo sapiens]
[EntityWithAccessionedSequence:5683111] ABCB1 S893A [plasma membrane] [Homo sapiens]
[ChemicalDrug:9660771] budesonide [extracellular region]
[ChemicalDrug:9660774] budesonide [cytosol]
[ChemicalDrug:9707190] olsalazine [cytosol]
[ChemicalDrug:9714285] methylprednisolone [cytosol]
[Complex:9795091] JOSD2:NLRP3 R779C [cytosol] [Homo sapiens]
List all 14 refering instances
[Change default viewing format]
No pathways have been reviewed or authored by inflammatory bowel disease (5683147)